Understanding Hepatic Encephalopathy and Prioritizing Care
The client’s presentation—altered mental status, asterixis, and a critically elevated serum ammonia level of
150 μmol/L—is a classic picture of an acute exacerbation of hepatic encephalopathy (HE). In cirrhosis, the liver’s capacity to metabolize neurotoxins like ammonia is severely compromised. While hyperammonemia is a central factor, current evidence emphasizes that systemic inflammation acts as a critical synergistic driver, amplifying ammonia’s neurotoxic effects on the brain
[1]. This means that clinical interventions must aggressively target ammonia reduction while also recognizing that inflammatory triggers, such as infection or electrolyte imbalances, can precipitate an episode
[2].
Analyzing the Priority Intervention
The core of immediate management for an overt HE episode is to lower the neurotoxin load.
Lactulose, a nonabsorbable disaccharide, is the standard first-line agent for this purpose [2,3]. Its mechanism of action is multifactorial and directly addresses the pathophysiology:
- It acidifies the colonic lumen, which converts diffusible ammonia (NH₃) into non-absorbable ammonium ions (NH₄⁺), trapping them in the gut.
- It exerts a cathartic effect, accelerating the expulsion of ammonia-producing bacteria and nitrogenous waste from the bowel.
- This dual action rapidly reduces both systemic ammonia levels and their deleterious impact on cerebral function, facilitating neurological recovery
[3].
Why the Other Options Are Not the Priority
-
Encouraging a high-protein diet: This is contraindicated during an acute HE episode. Protein metabolism in the gut is a primary source of ammonia production. Restricting dietary protein is a standard temporizing measure to prevent further exacerbation of hyperammonemia until the acute episode is controlled
[2].
-
Increasing fluid intake: While maintaining euvolemia is important, aggressive fluid loading is not a direct treatment for HE and could be dangerous in a cirrhotic patient with potential for ascites, hyponatremia, or fluid overload. The priority is to eliminate the precipitating toxin, not simply dilute it.
-
Administering sedatives: This is potentially catastrophic. The client’s altered mental status is a symptom of neurotoxicity, not a primary anxiety disorder. Sedatives, particularly benzodiazepines, are metabolized by the liver and can profoundly worsen encephalopathy by further depressing the central nervous system. A key principle of HE management is the elimination of precipitating factors, which includes avoiding sedating medications [2,3].
The nurse’s immediate priority is to administer the prescribed lactulose, which directly counteracts the underlying pathophysiology of ammonia-driven neurotoxicity and is the cornerstone of acute HE management according to current clinical guidelines [2,3].
References (research sources)
- [1]
The role of systemic inflammation in hepatic encephalopathy: advances in inflammatory mechanisms, prevention and treatment research.Research articleWang W, Wen Y. (2026) · DOI: 10.1080/07853890.2026.2650232
- [2]
Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024).GuidelineXu X, Ding H, Li W, Han Y, Guan Y, Xu J, Han Y, Jia J, Wei L, Duan Z, Nan Y, Zhuang H, Chinese Society of Hepatology, Chinese Medical Association. (2025) · DOI: 10.14218/jcth.2024.00484
- [3]
Hepatic encephalopathy: From novel pathogenesis mechanism to emerging treatments.Research articlePun CK, Huang HC, Chang CC, Hsu SJ, Huang YH, Hou MC, Lee FY. (2024) · DOI: 10.1097/jcma.0000000000001041